Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 بازدیدها
• 07/14/23
0
0
جاسازی کنید
administrator
مشترکین
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
SORT BY-
نظرات برتر
-
آخرین نظرات